135 related articles for article (PubMed ID: 24749839)
21. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
Rucińska M; Machaczka M; Załuska A; Skotnicki AB
Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
[TBL] [Abstract][Full Text] [Related]
22. [Hairy cell leukemia treated with cladribine].
Ghanima W; Heldal D; Tjønnfjord GE
Tidsskr Nor Laegeforen; 2002 Apr; 122(11):1094-7. PubMed ID: 12043051
[TBL] [Abstract][Full Text] [Related]
23. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V
Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series.
Rosenberg JD; Burian C; Waalen J; Saven A
Blood; 2014 Jan; 123(2):177-83. PubMed ID: 24192579
[TBL] [Abstract][Full Text] [Related]
25. Classical hairy cell leukemia and its variant: a 17-year retrospective survey in Taiwan Chinese.
Kao HW; Dunn P; Kuo MC; Shih LY; Lin TL; Wu JH; Tang TC; Chang H; Wu HC; Hung YS
Acta Haematol; 2011; 126(3):186-93. PubMed ID: 21846972
[TBL] [Abstract][Full Text] [Related]
26. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
[TBL] [Abstract][Full Text] [Related]
27. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
28. [Treatment for recurrent hairy cell leukemia].
Al'-Radi LS; Pivnik AV; Zingerman BV; Kravchenko SK
Ter Arkh; 2012; 84(7):4-9. PubMed ID: 23038964
[TBL] [Abstract][Full Text] [Related]
29. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
30. Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer Center.
Watts JM; Kishtagari A; Hsu M; Lacouture ME; Postow MA; Park JH; Stein EM; Teruya-Feldstein J; Abdel-Wahab O; Devlin SM; Tallman MS
Br J Haematol; 2015 Oct; 171(1):84-90. PubMed ID: 26115047
[TBL] [Abstract][Full Text] [Related]
31. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
[TBL] [Abstract][Full Text] [Related]
32. Cladribine in hairy cell leukemia.
Belani R; Saven A
Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111
[TBL] [Abstract][Full Text] [Related]
33. A population-based study of hairy cell leukemia over a period of 20 years.
Wiber M; Maitre E; Poncet JM; Duchenet V; Damaj G; Cornet E; Troussard X
Cancer Treat Res Commun; 2020; 25():100236. PubMed ID: 33227559
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of extranodal Hodgkin's lymphoma in a patient with longstanding hairy cell leukemia.
Gotic M; Cemerikic V; Elezovic I; Boskovic D; Bila J; Magic Z; Jocic DJ; Pavlovic D; Grujicic D; Stosic T; Wotherspoon A; Catovsky D
Leuk Lymphoma; 2005 May; 46(5):765-9. PubMed ID: 16019516
[TBL] [Abstract][Full Text] [Related]
35. Treatment of hairy-cell leukemia: current views.
Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A
Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
[TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.
Zinzani PL; Magagnoli M; Bendandi M; Tani M; Stefoni V; Cellini C; Poggi S; Piccioli M; Pileri S; Tura S
Haematologica; 2000 Sep; 85(9):922-5. PubMed ID: 10980629
[TBL] [Abstract][Full Text] [Related]
37. Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.
Zinzani PL; Pellegrini C; Stefoni V; Derenzini E; Gandolfi L; Broccoli A; Argnani L; Quirini F; Pileri S; Baccarani M
Cancer; 2010 Oct; 116(20):4788-92. PubMed ID: 20597132
[TBL] [Abstract][Full Text] [Related]
38. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia.
Brennan P; Coates M; Armstrong B; Colin D; Boffetta P
Br J Cancer; 2000 Apr; 82(7):1344-7. PubMed ID: 10755412
[TBL] [Abstract][Full Text] [Related]
39. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].
Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031
[TBL] [Abstract][Full Text] [Related]
40. Hairy cell leukemia: current concepts.
Cannon T; Mobarek D; Wegge J; Tabbara IA
Cancer Invest; 2008 Oct; 26(8):860-5. PubMed ID: 18798068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]